The Future of Vonoprazan PCD Pharma Business in India: What the...

hat ein neuen Blog hinzugefügt Health

2026-08-07 10:28:40 -

The Future of Vonoprazan PCD Pharma Business in India: What the Next Few Years Actually Look Like

Every so often, a single molecule reshapes an entire therapy category faster than anyone expects. In Indian gastroenterology, that molecule right now is Vonoprazan. Within a year of wider availability, Vonoprazan-based formulations became the best-selling new drug launch in the Indian Pharmaceutical Market, generating roughly ₹187 crore in sales across more than 400 brands, according to IQVIA's...

0 Kommentare 0 Geteilt 58 Ansichten 0 Bewertungen